Elad Moisseiev - research works

Patients had previously received intravitreal injections of medications including bevacizumab, ranibizumab, aflibercept 2 mg, brolucizumab, triamcinolone, and Ozurdex.

Following treatment with faricimab, the proportion of eyes with no intraretinal or subretinal fluid increased across all retinal diseases.

The average height of the pigment epithelium detachment (PED) decreased in cases of NVAMD and PCV.

F2F examination was predefined as the reference standard.

Of these, 217 eyes (50.94%) had neovascular age-related macular degeneration (NVAMD), 151 (35.45%) diabetic macular edema (DME), and 56 (13.15%) retinal vein occlusion (RVO; 36 branch RVO, 14 central RVO, and 6 hemi-retinal RVO).

One eye (0.23%) had myopic choroidal neovascularization (CNV), and one (0.23%) had Sorsby macular dystrophy with CNV.

The mean virtual review time was more than twofold shorter than the F2F evaluation ( P < 0.001).

All eyes with fovea-off RRD demonstrated retinal displacement, whereas 82% of fovea-on cases were displaced.

Inferior displacement was the predominant direction (80%), most commonly oriented inferotemporally.

Silicone oil tamponade was associated with reduced displacement severity and a higher rate of superior displacement compared with gas tamponade (P < 0.01).

Intraoperative perfluorocarbon liquid (PFCL) use was significantly associated with horizontal macular stretch (P = 0.04).

A total of 86 eyes of 85 consecutive patients, with mean age of 80.31 ± 8.06 and mean best-corrected visual acuity of 1.17 ± 0.58 logarithm of the minimal angle of resolution.

Two different subtypes of FTMHs were identified: tractional and degenerative.

Fifty (58%) degenerative FTMHs characterized with inverted trapezoid appearance and 36 (42%) tractional FTMHs characterized with hourglass appearance.

The presence of epiretinal membrane and pigment epithelium detachment where significantly higher in tractional FTMHs (P = 0.02, 0.03, respectively).